Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05RIY
|
|||
Former ID |
DIB003161
|
|||
Drug Name |
Perflubutane lipid microsphere-encapsulated
|
|||
Synonyms |
Imagify; Perflubutane; Perfluorobutane; Sonazoid; AI-700; DD-723; NC-100100; NUS, HafslundNycomed; New Ultra Sound, Hafslund Nycomed; Ultrasound contrast agent, GE Healthcare; Ultrasound contrast agent, Nycomed Amersham; DD-723-B; Perflubutane (ultrasound, myocardial perfusion), Acusphere; Perflubutane (lipid microsphere-encapsulated), Nycomed Amersham/Daiichi; Perflubutane (lipid microsphere-encapsulated, liver imaging), Daiichi Sankyo; Perflubutane (lipid-encapsulated) contrast agent, GE Healthcare/Daiichi; Perflubutane (polymer microsphere-encapsulated, heart disease), Acusphere
Click to Show/Hide
|
|||
Indication | Heart disease [ICD-11: BA41-BA42; ICD-9: 390-429] | Approved | [1], [2] | |
Company |
GE Healthcare; acusphere
|
|||
Structure |
Download2D MOL |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02489045) Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension. | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.